Back to Search Start Over

Magnetic resonance imaging of tumor-associated-macrophages (TAMs) with a nanoparticle contrast agent.

Authors :
Zhou, Junhan
Zhou, Junhan
Meli, Vijaykumar S
Yu-Tin Chen, Esther
Kapre, Rohan
Nagalla, Raji
Xiao, Wenwu
Borowsky, Alexander D
Lam, Kit S
Liu, Wendy F
Louie, Angelique Y
Zhou, Junhan
Zhou, Junhan
Meli, Vijaykumar S
Yu-Tin Chen, Esther
Kapre, Rohan
Nagalla, Raji
Xiao, Wenwu
Borowsky, Alexander D
Lam, Kit S
Liu, Wendy F
Louie, Angelique Y
Source :
RSC advances; vol 12, iss 13, 7742-7756; 2046-2069
Publication Year :
2022

Abstract

In the tumor micro-environment, tumor associated macrophages (TAMs) represent a predominant component of the total tumor mass, and TAMs play a complex and diverse role in cancer pathogenesis with potential for either tumor suppressive, or tumor promoting biology. Thus, understanding macrophage localization and function are essential for cancer diagnosis and treatment. Typically, tissue biopsy is used to evaluate the density and polarization of TAMs, but provides a limited "snapshot" in time of a dynamic and potentially heterogeneous tumor immune microenvironment. Imaging has the potential for three-dimensional mapping; however, there is a paucity of macrophage-targeted contrast agents to specifically detect TAM subtypes. We have previously found that sulfated-dextran coated iron oxide nanoparticles (SDIO) can target macrophage scavenger receptor A (SR-A, also known as CD204). Since CD204 (SR-A) is considered a biomarker for the M2 macrophage polarization, these SDIO might provide M2-specific imaging probes for MRI. In this work, we investigate whether SDIO can label M2-polarized cells in vitro. We evaluate the effect of degree of sulfation on uptake by primary cultured bone marrow derived macrophages (BMDM) and found that a higher degree of sulfation led to higher uptake, but there were no differences across the subtypes. Further analysis of the BMDM showed similar SR-A expression across stimulation conditions, suggesting that this classic model for macrophage subtypes may not be ideal for definitive M2 subtype marker expression, especially SR-A. We further examine the localization of SDIO in TAMs in vivo, in the mammary fat pad mouse model of breast cancer. We demonstrate that uptake by TAMs expressing SR-A scales with degree of sulfation, consistent with the in vitro studies. The TAMs demonstrate M2-like function and secrete Arg-1 but not iNOS. Uptake by these M2-like TAMs is validated by immunohistochemistry. SDIO show promise as a valuable addition to the toolki

Details

Database :
OAIster
Journal :
RSC advances; vol 12, iss 13, 7742-7756; 2046-2069
Notes :
application/pdf, RSC advances vol 12, iss 13, 7742-7756 2046-2069
Publication Type :
Electronic Resource
Accession number :
edsoai.on1367390148
Document Type :
Electronic Resource